Evidence map›Paper›PMID 40822593›Full record

ArticleFrontiers in cellular and infection microbiology2025

Genomic characterization of multidrug-resistant clinical

Sandra Sánchez-Urtaza, Laura Alfonso-Alarcón, Rocío Arazo Del Pino, Tessa Burgwinkel, Alain Ocampo-Sosa, Ruth Gonzalez, Kyriaki Xanthopoulou, Paul G Higgins, Itziar Alkorta, Lucia Gallego

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Carbapenem-ResistantMicroorganisms · 2026
    Article
  3. Whole-Genome Sequencing of Multidrug-ResistantInternational journal of molecular sciences · 2026
    Article
  4. Review
  5. Genomic characterization of carbapenem-resistantFrontiers in cellular and infection microbiology · 2026
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sandra Sánchez-Urtaza *Laboratory of Antibiotics and Molecular Bacteriology, Department of Immunology, Microbiology and Parasitology, Faculty of Medicine and Nursing, University of the Basque Country, Leioa, Spain.
Laura Alfonso-Alarcón *Laboratory of Antibiotics and Molecular Bacteriology, Department of Immunology, Microbiology and Parasitology, Faculty of Medicine and Nursing, University of the Basque Country, Leioa, Spain.
Rocío Arazo Del PinoInstitute for Medical Microbiology, Immunology and Hygiene, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Tessa BurgwinkelInstitute for Medical Microbiology, Immunology and Hygiene, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Alain Ocampo-SosaMicrobiology Service, University Hospital Marqués de Valdecilla, Health Research Institute (Instituto de Investigación Valdecilla), Santander, Spain and CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain.
Ruth GonzalezNational Hospital of Itaugua, Itaugua, Paraguay.
Kyriaki XanthopoulouInstitute for Medical Microbiology, Immunology and Hygiene, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Paul G HigginsInstitute for Medical Microbiology, Immunology and Hygiene, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Itziar AlkortaDepartment of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country, Leioa, Spain.
Lucia GallegoLaboratory of Antibiotics and Molecular Bacteriology, Department of Immunology, Microbiology and Parasitology, Faculty of Medicine and Nursing, University of the Basque Country, Leioa, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acinetobacter baumanniiAcinetobacter InfectionsDrug Resistance, Multiple, BacterialGenome, BacterialAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenemsCross InfectionGenomicsHospitalsHumansMicrobial Sensitivity TestsParaguayPlasmidsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenemsAcinetobacter baumanniiantibiotic resistanceepidemiologyParaguayplasmidswhole genome sequencing

Identifiers

PMID40822593
PMCPMC12350285

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.